Vitrafy Partners with Vitalant for Cryopreservation Ecosystem
Key points
- Vitrafy partners with Vitalant Innovation Center to address RBC preservation crisis
- Vitalant is the second-largest blood network in the USA
- Partnership aims to replace legacy technologies by 2027
- Opportunity to expand to other blood products
Full summary
Vitrafy Life Sciences Limited has announced a partnership with Vitalant Innovation Center to configure its next-generation cryopreservation ecosystem, aiming to solve the looming crisis for red blood cell preservation. Vitalant, the second-largest blood network in the USA, will contribute resources to deliver a market-wide solution. The partnership addresses the discontinuation of legacy technologies used to cryopreserve red blood cells, which are critical for long-term stockpiling and emergency supply readiness. Vitrafy plans to expand this solution to other blood products, potentially becoming the successor to existing end-of-life legacy technologies across the U.S. blood network.
Summary generated by a large language model. Please interpret with care.